Dr Angela Lamarca MD, PhD, MSc is a medical oncologist specialised in gastrointestinal malignancies (hepato-pancreato-biliary (HPB) and neuroendocrine tumours (NETs)). She completed her training in Medical Oncology (including her PhD) in Spain at the Hospital Universitario La Paz, Madrid.

She moved to The Christie NHS Foundation Trust in Manchester, United Kingdom in 2013, where she completed a 4-year fellowship programme in HPB and NETs. Dr Lamarca holds a Master’s Degree in Molecular Biology of Cancer and a second Master’s Degree in Biostatistics.

She was awarded an American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation Young Investigator Award in 2017. Dr Lamarca was appointed as a Consultant in Medical Oncology at The Christie NHS Foundation Trust in May 2018 where she practiced until May 2022 when she moved back to Spain at the Fundacion Jimenez Diaz University Hospital in Madrid to continue her clinical and research activities in HPB and NETs.

Dr Lamarca is a member of the ESMO Council by virtue of her role as Chair of the ESMO Communication Committee and ESMO Press Officer, she is also a member of the Nomination Committee, ESMO Guidelines Subject Editor for Endocrine and Neuro-endocrine Cancers, and holds a position in the ESMO Gastrointestinal Cancer, Upper digestive Faculty group. She is also Lead of the Biliary EORTC Gastrointestinal Cancer Group and a member of the ENETS Advisory Board and the ENS-CCA, TTD and GETNE Steering Committee.